Harald Stachelscheid

7PUBLICATIONS
55CO-AUTHORS
Environmental biogeochemistryCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 11, 2026
Comparative Evaluation of hiPSC-Derived Brain Organoids as Platforms for Assessing Thyroid Hormone System Disrupting Chemicals.

|Feb 10, 2026
Time‑resolved multi-omic analysis of paclitaxel exposure in human iPSC‑derived sensory neurons unveils mechanisms of chemotherapy‑induced peripheral neuropathy.

Christian Schinke, Smilla K Maierhof, Lois Hew

|Jan 21, 2026
Lung tumouroids as a testing platform for precision CAR T cell therapy.

Lukas Ehlen, Martí Farrera-Sal, Martin Szyska

|Nov 13, 2025
c-Jun inhibition mitigates chemotherapy-induced neurotoxicity in iPSC-derived sensory neurons.

Lois Hew, Smilla K Maierhof, Andranik Ivanov

|Jul 19, 2023
Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatment.

Lara Lechner, Robert Opitz, Matt J Silver

|Aug 19, 2021
COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.

Sanzio Dimai, Lukas Semmler, Ashok Prabhu

Pageof 2

Frequent Collaborators

2 joint publications

Silke Frahm

2 joint publications

Petra Huehnchen

2 joint publications

Matthias Endres

2 joint publications

Lois Hew